- Assistant Professor, CWRU School of Medicine
- Fatty Liver Disease
- Hepatocellular Carcinoma
- Liver Transplantation
- Portal Hypertension
- Viral Hepatitis
Patient Experience Reviews
4.6 out of 5
Patient Comments (7)
Reviewed On 12/1/2020
experience was very good
Reviewed On 9/1/2020
A very good Doctor !!!
Reviewed On 9/1/2020
Dr. Sclair is excellent. He is thorough with his diagnosis and informs me about current and future plans of treatment. He answers all of my questions and follows up quickly on all of my requests.
Reviewed On 5/1/2020
very informative, very considerate, and excellent instructions with treatment plan.
Reviewed On 3/6/2020
He was interested in my care and gathered information, conducted tests and labs and led me to the next level for review. ***
Reviewed On 2/25/2020
I have a good experience with the team.
Reviewed On 1/31/2020
- Transplant Hepatology - American Board of Internal Medicine
- Gastroenterology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Fellowship | Transplant Hepatology
Transplant Hepatology - Jackson Memorial Hospital/Jackson Health System (2015 - 2016)
Fellowship | Gastroenterology
Gastroenterology - Jackson Memorial Hospital/Jackson Health System (2013 - 2015)
Research Fellowship | Hepatology
Hepatology - University Of Miami Miller School Of Medicine (2011 - 2013)
Residency | Internal Medicine
Internal Medicine - Jackson Memorial Hospital/Jackson Health System (2009 - 2012)
Research Fellowship | Internal Medicine
Internal Medicine - ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (2007 - 2008)
New York Medical College (2009)
Brandeis University (2004)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Seth Sclair did not disclose any Outside Relationships with Industry.